A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

Summary

This is an open-label, single-dose study to evaluate the pharmacokinetics and safety of HSK21542 in subjects with mild, moderate and severe renal impairment compared to the matched control subjects with normal renal function.

Timeline

Start

2023-04-24

Primary completion

2023-07-30

Completion

2023-12-30

Drugs

Indications